Day: September 10, 2021

Entered definitive merger agreement with Biosight Ltd. to advance pipeline of clinical-stage oncology programs for solid tumors and hematological malignancies Initiated Phase 1 clinical trial of ADXS-504 for the treatment of early prostate cancer ADXS-503 Phase 1/2 data presented at ASCO demonstrate disease control rate of 44% with durable clinical benefit observed beyond one year in patients with disease progression on KEYTRUDA® MONMOUTH JUNCTION, N.J., Sept. 10, 2021 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announces its financial results for the third quarter ended July 31, 2021 and provides a business update. Third Quarter Ended July 31, 2021 Financial Results and Recent Key Accomplishments:Entered...

JUPITER, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving, applying, and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and therapeutics at flexible commercial scales, today announced that the Company’s management will be attending and presenting at the following upcoming virtual investor event: Event DetailsPresenter: Mark Emalfarb, CEO Date: Monday, September 13, 2021Time: 7:00 AM Eastern Time – Presentation will also be available on demand during the conference September 13 – 15, 2021Event Link: https://hcwevents.com/annualconference/ Dyadic...

LAS VEGAS, Sept. 10, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Golden Triangle Ventures, Inc. (OTC PINK: GTVH) is pleased to announce its Entertainment Division, Lavish Entertainment, Inc., has released its debut experimental bass music album under the Company’s recently formed Record Label, Syndicate Bass Records. The Company has the revolutionary vision to highlight music and visuals on one label by launching animations in concert with each song and distributing this unique content on global streaming video platforms such as YouTube, Vimeo, Twitch and many more. This debut record release will also be available on all major audio streaming platforms such as SoundCloud, Spotify, Apple Music and more. Formed by individuals who believe strongly in the impact of the bass music scene around the world, Syndicate Bass Records...

NEW YORK and LONDON, Sept. 10, 2021 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LTB4) systems are implicated, today announced that Miles Nunn, Ph.D., Chief Scientific Officer of Akari Therapeutics, and Sanjeev Khindri, M.D., Medical Director of Akari Therapeutics, will present a poster outlining the design of the Company’s Phase III planned pivotal study of nomacopan in patients with moderate to severe bullous pemphigoid (BP) at the 2021 International Pemphigus & Pemphigoid Foundation (IPPF) Scientific Symposium. The IPPF’s main focus is to improve the quality of life for all those affected by pemphigus and pemphigoid through early diagnosis...

Preliminary findings from ongoing Phase 1 healthy volunteer study will include data relating to mechanism of action; optimal dose; and time to onset, duration and magnitude of pharmacodynamic effects Final data from completed Phase 1b study in patients with small cell lung cancer (SCLC) receiving topotecan supporting best-in-class potential of ALRN-6924BOSTON, Sept. 10, 2021 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, today announced two upcoming poster presentations at the European Society of Medical Oncology (ESMO) Virtual Congress 2021, which is being held September 16-21, 2021. In these posters, Aileron will present preliminary data from its ongoing Phase 1 study of ALRN-6924 in healthy...

TORONTO, Sept. 10, 2021 (GLOBE NEWSWIRE) — CF Energy Corp. (TSX-V:CFY) (“CF Energy” or the “Company”; together with its subsidiaries, the “Group”), a leading new energy service provider in the People’s Republic of China (the “PRC” or “China”), is pleased to announce that the Company’s Haitang Bay Integrated Smart Energy Phase One Project has successfully commenced operation in September of 2021. The first group of commercial customers received the district cooling supply service from the Company includes The Sanya Edition Hotel, Fairmont Sanya Haitang Bay and Westin Sanya Haitang Bay Resort. The DoubleTree Resort by Hilton is also expected to be connected upon its completion of renovations. The collective cooling space of these customers is about 195,040 square meters. The Company has signed up nine commercial customers in Haitang...

SAN CARLOS, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) — We are advised by Check Point Software Technologies Ltd. that journalists and other readers should disregard the news release, “August 2020’s Most Wanted Malware: Evolved Qbot Trojan Ranks On Top Malware List For First Time” issued September 10, 2021 over GlobeNewswire.

COMPANY ANNOUNCEMENT NO 44/2021 – 10 SEPTEMBER 2021 In continuation of company announcement, no 37/2021, which was published on 1 July 2021, Royal Unibrew is happy to announce that the acquisition of Solera Beverage Group has been approved by the Finnish Competition and Consumer Authority today and that closing of the deal will happen within the next few days. As previously announced, Royal Unibrew has agreed to acquire Solera Beverage Group from the private equity fund, CapMan, at an enterprise value of around DKK 770 million (NOK 1.1 billion) on a debt free basis. Solera Beverage Group has around 150 employees and generates normalized revenue (excluding positive COVID-19 effects) of around DKK 1.3 billion and a normalized EBITDA of around DKK 70 million. Solera Beverage Group is a leading importer and distributor of a strong portfolio...

CORAL GABLES, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases, today announced that Patrick J. McEnany, Catalyst’s Chief Executive Officer and Steven Miller, Ph.D., Chief Scientific Officer /COO, will participate in two upcoming investor conferences:The H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021. Catalyst’s pre-recorded presentation will be available for viewing on-demand beginning Monday, September 13, 2021, at 7:00 AM EDT for those registered for the event. Catalyst’s management will host virtual 1×1 meetings throughout the day.2021 Cantor...

Los Angeles CA, Sept. 10, 2021 (GLOBE NEWSWIRE) — CurrencyWorks Inc. (“CurrencyWorks” or the “Company”), (CSE: CWRK and OTCQB: CWRK), a full service blockchain platform provider, today announced that it will be featured as a presenting company at the H.C. Wainwright 23rd Annual Global Investment Conference. The conference is taking place virtually from September 13-15, 2021. Cameron Chell, Executive Chairman of CurrencyWorks, will provide an overview of the Company’s business during the presentation. If you are an institutional or retail investor, and would like to listen to the Company’s presentation, please click here to register for the conference. The Company’s presentation will be available online starting on September 13th at 7:00 A.M. (ET). It will be archived for 90 days. Dozens of corporate presentations and panels...